ASX Archives - Atomo Diagnostics

10 Sep Interview with Proactive Investors

Posted at 20:54h in News by Rebecca James 0 Comments

0 Likes

Managing Director, John Kelly speaks to Proactive about the broad applications for Atomo’s rapid blood-based tests at the ASX Small and Mid-Cap Conference. [embed]https://www.youtube.com/watch?v=wl4xxnxZ198[/embed]...

11 Aug Biotech Dispatch: Approval for Atomo Diagnostics’ Rapid Antibody Test

Posted at 21:08h in News by Rebecca James 0 Comments

0 Likes

Atomo Diagnostics (ASX: AT1) has announced approval of it’s antibody blood test for use by medical professionals in Australia. Read the full article > ...